Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women

NCT00000809 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections
HIV Seronegativity

Interventions

BIOLOGICAL: Aluminum hydroxide
BIOLOGICAL: QS-21
BIOLOGICAL: MN rsgp120/HIV-1

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)